SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-006213
Filing Date
2017-04-07
Accepted
2017-04-07 16:15:59
Documents
5
Period of Report
2017-05-23
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A vktx-def14a_20170523.htm DEF 14A 790092
2 GRAPHIC g201704060109310313342.jpg GRAPHIC 3448
3 GRAPHIC g201704060109390793344.jpg GRAPHIC 81608
4 GRAPHIC g201704060109308353341.jpg GRAPHIC 3448
5 GRAPHIC g201704060109390533343.jpg GRAPHIC 44899
  Complete submission text file 0001564590-17-006213.txt   975461
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37355 | Film No.: 17749694
SIC: 2834 Pharmaceutical Preparations